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AbstrACt
Objectives To investigate the experiences and views 
of people living with posterior cortical atrophy (PCA), 
their family carers and healthcare professionals of vision 
assessment tests.
Design A qualitative investigation using video recordings 
of vision assessments, semistructured interviews and 
audio recordings of a focus group. Interviews and focus 
group used broad, open questions around the topic to 
prompt and guide discussion. Video and audio recordings 
were transcribed, manually coded and analysed using 
framework analysis.
setting University College, London's Queen Square 
neurology centre provided the venues for all stages of the 
research.
Participants Participants living with PCA were one 
male and two females (age range 67–78 years). Health 
professional participants were a neurologist (male), two 
ophthalmologists (male) and an optometrist (female).
Primary and secondary outcomes (1) Experiences 
and attitudes of people living with PCA and health 
professionals to vision assessment tests, (2) views of 
health professionals and people living with PCA of whether 
some tests are more effective at discriminating between 
cortical vision problems and vision problems related to 
optical or ocular causes.
results Patients were able to engage with and complete 
a number of tests. Their partners played a vital role in 
the process. Participants reported that simple, short tests 
were more effective than more subjective tests. Examples 
of tests that appeared to be more problematic for the 
patient participants were the Amsler Grid and visual field 
analysis.
Conclusions Although limited in scope and execution, 
the project suggests that some vision assessment tests 
are likely to support health professionals to discriminate 
between cortical and optical/ocular causes of visual 
impairment. It supports existing evidence that there are 
vision assessments that people with dementia can engage 
with and complete. We identify areas of importance for 
future research and make tentative suggestions for clinical 
practice.
IntrODuCtIOn   
Posterior cortical atrophy (PCA) involves 
progressive visual dysfunction and a degen-
eration of the posterior brain’s outer layer 
(the cortex). It is most commonly caused 
by Alzheimer’s disease, although may also 
be caused by dementia with Lewy bodies, 
corticobasal degeneration or Creutzfeldt-
Jakob disease.1 The visual dysfunction experi-
enced can encompass aspects of visuospatial 
and visuoperceptual processing. Features 
of Balint’s syndrome (eg, simultanagnosia, 
oculomotor apraxia) and of Gerstmann’s 
syndrome (including acalculia and agraphia) 
are common.2–4
First described in 1988, consensus criteria 
for PCA have only recently been agreed5 and 
diagnosis is often delayed or absent. The 
fact that it often goes unrecognised means 
that a prevalence figure is hard to estimate 
(some studies have suggested about 5% of 
those diagnosed with early onset Alzheimer’s 
strengths and limitations of this study
 ► Small sample of patients took part in the study.
 ► Potential variation in the relative progression of pos-
terior cortical atrophy between the participants may 
have been a confounding factor.
 ► Undertaken outside of usual clinical settings (due 
to multidiscipline approach), so patients might have 
performed differently in each discipline’s normal 
clinical environment.
 ► Views on the experiences of both patients and prac-
titioners in relation to each consultation captured 
separately, verbatim and on the day the consulta-
tions were undertaken.
 ► Multidisciplinary approach, incorporating optomet-
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disease may have PCA6). Most Alzheimer’s disease cases 
appear in people over 65, but PCA tends to occur between 
50 and 65.7 8
People living with PCA often present to optometrists 
and ophthalmologists with non-specific visual problems, 
but unless the clinician specifically looks for the signs 
and symptoms of PCA, it may not be picked up. It is not 
uncommon for people living with PCA to report delays 
from first presentation with visual symptoms to final 
diagnosis of PCA of many years. Investigating how vision 
assessment is experienced by people living with PCA, and 
the health professionals’ perspectives of conducting such 
assessments may offer insights into how to improve the 
process, and could provide scope for identifying tests 
that may be particularly useful in supporting clinicians to 
distinguish between visual symptoms with optical/ocular 
causes and those with cortical origins.
Individuals with PCA offer a unique perspective on 
the visual difficulties which may be experienced by many 
individuals with typical Alzheimer’s, at a point when the 
memory, language and insight problems of the latter 
group limit their ability to communicate what they are 
experiencing. Also, the nature of cortical visual problems 
in PCA can confound the use of standard optometric 
assessments. For example, the majority of PCA patients 
have normal or near-normal visual acuity, yet may struggle 
with a standard Snellen letter chart because of a reduced 
effective field of vision, and so can find it easier to read 
smaller, rather than larger, fonts. They may also struggle 
with excessive visual crowding in their central vision, 
resulting in difficulty reading letters surrounded by other 
letters or clutter,9 another common trait of optometric 
testing charts.
PurPOse
The complexities of both diagnosing PCA5 10 and the 
reality that—given the complexities introduced by the 
cortical visual perceptual symptoms associated with PCA—
it may be complicated for optometrists and ophthalmolo-
gists to work with people living with PCA to find the most 
appropriate approach to correcting visual impairment (to 
produce the best possible visual experience) presented 
an opportunity for productive collaboration across the 
disciplines of optometry, ophthalmology, neurology and 
neuropsychology, to investigate the following research 
questions:
 ► How do people living with PCA experience various 
tests used to assess vision? What are the experiences of 
health professionals of administering these tests when 
examining people living with PCA?
 ► Are there particular tests for assessing vision that are 
more effective at discriminating between cortical 
vision problems and vision problems related to optical 
or ocular causes?
Qualitative methodologies, such as semistructured 
interviews, focus groups,11 and content analysis (or 
video/audio transcripts for example) offer an effective 
way to collect information about what patients think, how 
they think or why they may hold a particular view. Inter-
actions between participants in groups can encourage 
participants to explore and clarify individual and shared 
perspectives and may support participation by people 
who may be reluctant to contribute their views in a more 
formal one-to-one scenario12
There is limited qualitative evidence from people living 
with PCA or the health professions involved in assessing 
vision for individuals in this group about the experiences 
of having vision assessed or assessing vision. In particular, 
there is little patient and clinician data about the expe-
rience of administering or being assessed using various 
standard tests. Focus groups have been used in a small 
number of studies to examine the general experiences 
of people living with conditions such as glaucoma, which 
require regular vision assessments.13 14
However, there is limited evidence relating to the opin-
ions of patients living with PCA, or clinicians, about the 
tests used to assess vision. Anecdotal evidence suggests 
that patients dislike performing the visual field test, but 
no study has interviewed patients living with PCA in detail 
about their perceptions of the tests used by various health 
professionals to assess vision and visual perception. Such 
evidence could begin to shed light on how tests are expe-
rienced, and whether some tests may prove both more 
acceptable/accessible, and better able to support profes-
sionals in discriminating between cortical and optical/
ocular causes of visual problems.
This project was structured as an initial exploration of 
the qualitative experiences of people living with PCA and 
health professionals. The project was designed to gather 
rich qualitative data, although the limited sample size 
reduced the scope for definitive conclusions in relation 
to these questions to be reached. The intention was to 
explore the potential for gathering and analysing this 
type of data, with this participant group, with a view to 
informing the development of subsequent research. In 
addition to investigating the viability of such research, 
the project was intended to provide some insights into 
potential target tests and vision assessment methods of 
particular interest, to enhance and inform clinical prac-
tice and increase awareness of dementia-related cortical 
visual impairment through improved training and access 
to resources. It was also anticipated that it might enable 
further research to be more focused.
MethODs
Participants
Vision assessments and postassessment interviews took 
place over the course of a day at University College 
London's (UCL) Dementia Research Centre at Queen 
Square in London, in February 2016. This location was 
selected as it was familiar and accessible to participants 
living with PCA, convenient to the clinicians participating 
and had the scope to support the relevant equipment 
and filming required. A focus group was then held for 
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the health professionals involved (as well as one other 
ophthalmologist invitee) in March 2016, to analyse 
footage selected from the vision assessments (footage was 
selected by HZ and MB initially, and reviewed by SC and 
TS before inclusion) and discuss a schedule of questions 
developed by the study team.
The study used purposeful sampling, whereby suitable 
participants living with PCA were selected by the UCL 
team from the Rare Dementia Support PCA support 
group membership15 ( www. raredementiasupport. org), 
based on their ability and willingness to attend and on 
the need to have participants with a range of PCA presen-
tations. Participants with PCA had a diagnosis consistent 
with the core clinicoradiological syndrome.10 Although 
all individuals presented with progressive decline in 
visual processing and relatively intact memory in the 
early stages, some impairments of episodic memory were 
apparent at the time of this study.
At present in the UK, many people living with early PCA 
are first referred into secondary care services by optome-
trists working in community settings. These referrals are 
frequently not identified as suspected PCA and due to 
the lack of any current referral pathways from primary 
care optometry to secondary care neurology services, 
the referral route is nearly always to the optometry or 
ophthalmology functions of hospital eye services. For 
these reasons the project aimed to include vision testing 
techniques from several different healthcare disciplines, 
to gain insights into possible differences at the various 
access and referral points. This meant that the logistics 
of the testing and interview schedule (in particular the 
time taken to complete each stage) restricted the number 
of participants to three people with PCA (one male, two 
females, age range 67–78).
Participants with PCA were given an information sheet 
with brief details of the purpose and programme of the 
day—to gather data about the experience of having 
vision and eye health assessed by a range of clinicians. 
A member of the research team provided the informa-
tion verbally to participants with reading difficulties and 
checked with each participant that they had understood 
the information provided and answered any questions 
that the participant or their family member had. Written 
consent to participate in the research was received, along 
with written consent relating to the video recording of 
the examination sessions and interviews. Participants 
were informed in writing and reminded verbally on the 
day that they could withdraw from the project at any time. 
Each participant with PCA was accompanied by a family 
member throughout the processes of the day.
Three clinicians took part on the vision assessment 
day—an optometrist, a neurologist and an ophthalmol-
ogist (one female and two males), and they were given 
briefing information about the testing they would be 
asked to carry out and the post-testing interviews. Consent 
for participation and video recording of the assessments 
and audio recording of the focus group was received from 
each of the professional participants. The professional 
participants had varying experience of assessing vision in 
people with dementia or PCA. The optometrist had more 
than 20 years of experience in primary and secondary 
care settings, and had encountered numerous people 
living with dementia and some people living with PCA. 
The neurologist was an experienced consultant neurolo-
gist with more than 20 years of clinical and research expe-
rience working with numerous people living with PCA. 
The ophthalmologist was more recently qualified, and 
had encountered few people living with PCA.
The study conformed to the Declaration of Helsinki.
Procedure
Each patient participant completed three sequential 
vision assessments with an optometrist, ophthalmologist 
and neurologist, with their partner in attendance. After 
each assessment, the patient participant and their partner 
completed a brief interview, as did each clinician.
In advance of the testing day, semistructured interview 
schedules were developed for the postexamination inter-
views with the clinicians and people with PCA. Following 
the day of vision assessments, HZ and MB prepared a 
schedule of questions/topics for the clinicians' focus 
group (which took place two weeks after the vision assess-
ment day to allow time for video footage to be reviewed 
and selections made for presentation to the focus group), 
informed by the themes arising during the eye examina-
tions and postexamination interviews.
Vision assessment protocol
Each of the three health professionals was asked to assess 
the vision of each of the three participants in a manner 
that followed as closely as possible the methods they 
would use in their usual clinical practice.
These broad test protocols equated to: optometrist—
primary care general ophthalmic services sight test16; 
ophthalmologist—general secondary care hospital eye 
service general referral (refraction clinic) vision assess-
ment; neurologist—the visual perceptual elements of a 
routine neurological examination.
Each clinician was provided with as much of the equip-
ment for assessing vision that they would usually have 
available.
Equipment available was as follows:
 ► Hand held slit lamp (Keeler).
 ► Tonometer - CT-80 (table mounted).
 ► Field screener - Henson 9000.
 ► Ophthalmoscope.
 ► Retinoscope.
 ► Indirect ophthalmoscope (Keeler).
 ► Prism bar.
 ► Cross-cyl test lenses.
 ► Trial frame.
 ► Trial frame lens set.
 ► Focimeter (Pentax).
 ► Volk lens.
 ► 20D lens
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Tests/charts:
 ► Standard Snellen chart.
 ► Thompson Software Electronic test chart software 
(running on an Apple iPad)—including cross-cyl and 
near reading.
 ► Near reading test chart - cards.
 ► Ishihara colour vision test cards.
 ► Frisby stereo test chart.
 ► Cardiff cards or Teller visual acuity cards.
 ► The Queen Square Screening Test for Visual Deficits 
(The Blue Book).16
 ► The Queen Square Screening Test for Cognitive Defi-
cits (The Green Book).16
As the primary objective of the study was not to investigate 
a specific vision assessment procedure, or test sequence, 
the health professionals were not given a specific sequence 
for test elements. They were asked to take the approach 
to vision assessment/sight testing that they would usually 
follow in their practice setting.
These were the agreed key assessments that the health 
professionals suggested would generally be included in 
their usual assessments:
Neurologist’s assessment:
 ► Medical history.
 ► General examination.
 ► Eye signs (visual fields on confrontation, eye 
movements).
 ► Limb signs.
Ophthalmologist's/optometrist’s assessment:
 ► Medical history.
 ► Ophthalmoscopy.
 ► Retinoscopy.
 ► Slit lamp examination.
 ► Subjective and objective refraction.
 ► Convergence.
 ► Ocular motility.
 ► Pupil reflexes.
 ► Intraocular pressure (tonometry).
 ► Visual fields.
 ► Accommodation.
The order of optometry, ophthalmology and neurology 
assessments was varied between participants in an ABC 
BCA CAB design, with each assessment followed by an 
interview.
Interview and focus group procedures
The interview and focus group schedules were devel-
oped following initial discussions within the study team. 
The topics identified and included within the sched-
ules served only as a guide for the interviews and focus 
group. The order in which topics were addressed in inter-
views was not rigidly applied and question wording was 
not prescribed in advance. Where considered helpful, 
prompts were used by the interviewer/focus group facil-
itator to introduce topics and to encourage participants 
to expand on their comments. However, the core of the 
discussion came from the participants and care was taken 
to use open questions and to avoid unduly leading the 
conversations.
Although the patient participants were aware that 
they were going to have their eyes examined and vision 
assessed by the clinicians, they were not made explicitly 
aware of the focus of the study being to identify how tests 
were experienced and whether any tests were particularly 
good or bad when being used with someone with PCA. 
All interviews, and the facilitation of the clinicians' focus 
group, were conducted by one of the investigators (HZ). 
The professionals' focus group was cofacilitated by MB. 
The interviewer and participants had not met each other 
prior to the testing day, so introductions were made prior 
to the first interviews. In addition to the video recordings, 
the interviewer took field notes during the interviews. 
This note taking was intentionally kept to a minimum 
to enable the interviewer to attend as fully as possible to 
the interviews. During the focus group other members of 
the investigation team took notes to free the facilitator to 
focus on the discussion.
Each postexamination interview lasted around 5 min—
these interviews were intentionally kept brief to manage 
the time/energy demands of a long day of testing for 
the participants. Each filmed examination session lasted 
approximately 20–30 min. The clinicians' focus group 
lasted for about three and a half hours, with a 15 min 
break in the middle.
Consolidated Criteria for Reporting Qualitative 
Research guidelines were followed in the design and 
reporting of the study.17 A Systematic Reporting of Qual-
itative Research checklist was completed to ensure that 
the final paper complied with these guidelines.18
Patient and public involvement
The research question was developed following patient 
and public data collected during the PrOVIDe study (708 
participants),19 and also from discussions with members 
of the UCL PCA Support Group at one of their regular 
meetings (60 attendees).
Potential participants (members of the UCL PCA 
Support Group) were asked about the feasibility of the 
design, and any specific concerns and interests prior to 
the final design being confirmed.
Patients were not directly involved in the collection 
or analysis of data in this project, nor in the process of 
recruiting participants.
All those who participated were informed of the 
outcomes of the vision assessments where these indicated 
the need for further investigation/referral. Participants 
will receive a copy of the final report and any publications, 
and these will also be shared with the wider membership 
of the PCA Support Group and other relevant patient 
networks. Notice of papers will be given in the Alzhei-
mer’s Society patient publication.
This study was not a randomised controlled trial, 
so there was no trial-related requirement to assess the 
burden of the intervention on the patients. However, the 
team gave careful thought to the schedule for the day, 
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the provision of breaks and rest periods and made clear 
to participants that if the process was too tiring that they 
could rest or drop out at any time.
AnAlysIs
All vision tests/eye examinations and postexamination 
interviews were video recorded. The clinician focus 
group was audio recorded. The dialogue from the video 
and audio recordings was transcribed and reviewed by 
the investigators. In a small number of instances certain 
words were inaudible on the recordings, so field notes 
were used to account for any unclear information in 
those sections. All transcripts were pseudonymised.
The project followed an approach that was broadly 
constructivist and founded in the concepts of grounded 
theory. Data were analysed by two of the authors (MB and 
HZ) independently using framework analysis20 21 as shown 
in table 1. An inductive approach was taken to coding 
and analysis. Each investigator read and re-read the tran-
scripts and manually identified the key themes from the 
data. Once the investigators had both completed their 
independent theme identification, they met to review 
respective themes and organise the thematic framework, 
condensing and refining the categories that had been 
identified and identifying additional themes for explo-
ration. Any differences of opinion regarding the relative 
importance of themes, or the meanings of sentences were 
discussed until a consensus was reached.
Findings
Initial coding was completed according to the themes 
identified and agreed following stages 1 and 2 of the 
framework in table 1. During coding additional themes 
were identified. There were also occasions where it 
became clear during the coding process that themes 
initially considered distinct were actually either a single 
theme or a theme and very closely linked subtheme. 
Themes and subthemes are summarised in figure 1.
results
All of the participants were able to complete the full 
sequence of vision assessments with each of the partici-
pating professionals. However, within each assessment 
there was variation regarding the participants’ ability to 
complete individual tests. Although 45 min was allowed in 
the schedule, with the exception of the neurologist, the 
professional participants found it difficult to complete 
the tests within the time, or found that the patient partic-
ipants were finding the testing tiring.
the test experience
Clinicians reported that it was difficult to take a reliable 
history because of patient memory problems. They found 
that the simple, short tests appeared to work the best. 
Tests that included too many variables appeared to be less 
readily administered and were agreed to be likely to be 
less effective with these three patients. Examples of tests 
that appeared to be more problematic for the patient 
participants were the Amsler Grid22 and visual field anal-
ysis. Other optometric, ophthalmic and neurological tests 
were generally reported by the clinicians as appearing to 
be more effective; however, more subjective tests such as 
colour vision, depth perception and visual acuity were 
reported by patient participants as being, or seemed to 
clinician participants to be, more difficult for the patient 
participants. This was reported as apparently being due 
to either difficulty in understanding and/or retaining the 
instructions or visuoperceptual problems in completing 
the test, or some combination of these. A neuropsycho-
logical test using full and fragmented letters or images 
(see figure 2) appeared to offer potential as a screening 
test to discriminate between optical/ocular vision prob-
lems and cortical visual deficits. This type of test had 
the benefit of being short and simple. The professional 
participants agreed that this would be a good target for 
further research.
Clinicians noted that patients were affected by their 
involvement in one test after another. Fatigue was defi-
nitely a factor by the end of the day and within the test 
process. Patients would become more distracted, for 
example when their second eye was being tested. This 
meant that the time that testing took was significant. Too 
long and the patient may become too tired to continue 
without a break. Also, the testing process was particularly 
challenging for patients as it explored skills that they 
were once proficient in such as reading, but now find a 
struggle. Testing provided constant reminders of this.
All three patients attempted reading. This is chal-
lenging for the patients as it is an aspect of real life 
Table 1 Framework technique used for data analysis
1. Familiarisation Manuscripts are read and 
re-read independently by 
investigators.
2. Identifying thematic 
framework
Themes are identified and 
then reviewed jointly and 
a refined/condensed set of 
themes agreed on.
3. Coding/indexing Codes are applied to the 
data systematically by both 
investigators independently. 
Coding is then reviewed 
and discussed until final 
consensus on coding is 
reached.
4. Charting Data is rearranged in line 
with thematic content in 
a manner that supports 
cross-case and within-case 
analysis.
5. Mapping and interpretation Data is interpreted 
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they are concerned about anyway. I also checked to 
see if using your finger as a guide helped with reading 
but it did not. (Clinician interview 12.2)
Patients gave two reasons why they had volunteered to 
be involved in the testing day. First, it was a chance to 
contribute to research into a greater understanding of 
PCA, as patients had had difficulties in gaining an accu-
rate diagnosis of their condition in the first place. Second, 
it was a chance to find out more up-to-date information 
about how their disease was progressing and to check 
their vision.
Patients recognised that vision assessments were gener-
ally necessary.
It is as if I have been smacked in the face … that sort 
of feeling that you get when you have blown your 
nose too hard or been hit in the nose. So that is a 
physical feeling. It’s almost like little hooks being 
pulled around the eye, it’s quite hard work. (Patient 
interview 3.4)
Although they all remained positive about the process 
of repeated vision assessments on the day, and were made 
aware of the fact that they could stop at any point during 
the day they also found it uncomfortable and emotional 
at times, as it focused on what they were not able to do. 
As well as reporting tiredness, it could be experienced as 
physically unpleasant as well.
Patient responses varied greatly across the tests. Some 
they found easy to do, some were difficult, while one or 
two they could not do at all. All patients reported posi-
tively on the clarity of explanation of the test elements 
by each clinician. They welcomed the fact that key infor-
mation was repeated at intervals. These reminders of the 
key project information included research team members 
Figure 1 Themes and subthemes identified. NHS, National Health Service.








pen: first published as 10.1136/bmjopen-2017-020905 on 20 March 2019. Downloaded from 
7Bowen M, et al. BMJ Open 2019;9:e020905. doi:10.1136/bmjopen-2017-020905
Open access
checking that participants were happy to continue and 
ensuring that they were aware that they could take addi-
tional breaks between the sessions if they wished to. Tea/
coffee and juice/water were available to participants on 
request, and were regularly offered.
Patients’ partners played a vital role in the testing 
process. This role went beyond encouragement and 
support. It was about helping and prompting patients 
where they had memory lapses. They had shared patient 
frustrations when it had been difficult for clinicians 
despite many tests to diagnose PCA in the first place. 
Patients could turn to their partners for assurance during 
the tests, which could be given simply as a nod of encour-
agement or the prompt of a correct word.
The real crux of it is to recognise the move from eyes 
to brain. I am not sure still from the sort of ophthal-
mic tests we had, which are fairly standard eye tests 
that even a competent ophthalmologist would pick 
up necessarily that it is a brain disorder, that it is to do 
with processing the information. (Partner comment 
in patient interview 6.8)
Identifying cortical perceptual problems
The clinicians reviewed their experience of working with 
patients with PCA. They argued that it is important to look 
at two different aspects of care, prediagnosis and postdiag-
nosis. Prediagnosis there were real concerns about a wide 
range of clinicians who could potentially be involved, 
but who may find it difficult to identify suspect-PCA or to 
discriminate between optical/ocular vision problems and 
cortical perceptual issues.
They come in saying I’ve got a problem with my eyes, 
I can't see things and we do our examination and say, 
actually no, we can't really find any deficit at all, back 
you go to your GP and really the diagnosis would po-
tentially be missed. (21 merged coding)
They could include optometrists, ophthalmologists, 
neurologists and general practitioners. If it was possible 
to develop a simple test or series of tests to give an indi-
cation that a visual perceptual deficit or condition such 
as PCA may be involved, then this would be a significant 
step forwards and avoid a situation where patients visit a 
number of clinicians without anyone coming up with a 
firm diagnosis. This would also have potential for primary 
care settings as well. One clinician also thought it would 
be useful to involve orthoptists.
Post diagnosis it is still very important that the pa-
tient is able to access primary eye care so that they get 
monitoring of their general eye health and accurate 
correction of vision defects. (76 merged coding)
Patients thought that they fell between different clinical 
disciplines, going from one to another with no definitive 
diagnosis. Patients often reported a number of common 
symptoms. These included not being able to read dot 
matrix signs in the underground or on buses, and dislike 
of shiny surfaces and down escalators. A particular frus-
tration was the ability to read, which might come and go 
in some patients, or be fully lost for others.
I was constantly being bumped from pillar to post 
either at the hospital ophthalmic department or an-
other trying to work out why I couldn’t read properly 
and everything was falling off…things would slide off 
the page, I would say like icing off a cake. (Patient 
interview 3.9)
As a result of this, a key priority for patients and their 
partners was that appropriate systems were in place 
to enable early identification of PCA by primary and 
secondary care professionals. This meant that a consistent 
approach was needed across optometry, ophthalmology 
and neurology, with clear, effective and prompt commu-
nication and referrals between clinicians.
learning from the tests
Clinicians reviewed the learning from the project testing 
through detailed discussions in the focus group. There 
were a number of issues which emerged from this. Using 
a chart with lines of letters was far less effective than 
presenting patients with images of single letters. Multiple 
lines often caused patients to mix up letters on different 
lines. A simple test which contrasted full and fragmented 
images or letters was agreed to be the test that provided 
clearest evidence of PCA, or symptoms of other cortical 
vision problems, as patients could identify the full image 
but not the fragmented one. This worked with a letter or 
another object as the image. Another test was found to be 
to use photographs of common objects, but from unusual 
angles. Patients also experienced other symptoms which 
while not necessarily unusual for people living with PCA 
or other cortical visual problems, would be relatively 
uncommon in most primary care eye health settings.
For example, one said she could identify a small crumb 
on the floor but yet not see a glass on the table. One 
neurological test looked at visual disorientation. The 
patient was asked to grasp the clinician’s finger, but was 
often unable to do so. It is not uncommon for visual field 
defects to be confused with problems and disorders of 
spatial cognition (such as simultanagnosia)23 which may 
lead to eye health professionals missing a cortical problem 
such as PCA. For example, people with simultanagnosia 
may have serious problems performing perimetric tests 
(and thus appear to have limited visual fields), while their 
visual field may be intact in terms of their optical system 
and ocular health.24
I ask patients to grab my finger. This can look like a 
field defect, but it is not. Patients can see the hand 
and can copy the hand movement, yet cannot locate 
the finger in space. There is an unusual visual field 
and visual disorientation. (Clinician interview 12.4)
One clinician noted that it would be useful to include 
a routine slit lamp investigation with the tests in order 
to help determine the presence/absence of retinal 
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pathology. Patient participants did however report that 
the slit lamp examination was one of the most unpleasant 
parts of the optometric assessment. Another thought that 
it might be worth trying other field test approaches such 
as confrontation fields or some of the more recent tablet-
based field tests. Patients experienced particular prob-
lems with the visual field analysis. One patient could not 
see the light at all, while it 'came and went' for another 
patient. It is possible that this was due to optic ataxia, 
which is not uncommon among people living with PCA, 
but in primary eye health practice or general ophthal-
mology clinics this might not be readily seen as the most 
obvious explanation for such an observation.25
Can you see the light?’ and I had to say no, I couldn’t. 
He said, “Can you tell me where the light is?” and I 
said, “What light?” (Patient interview 4.5)
Patients and partners noted that there could be a 
cumulative effect of testing which involved things that 
they could not do, or skills they had lost. This increased 
fatigue and made concentration harder. Sometimes a 
break was needed.
Patients demonstrate awareness that their own memo-
ries could be erratic and unreliable. They were also aware 
that they could have good and bad days. These factors 
seemed to be driving the patient and carer view that 
the test process needed to be flexible enough to accom-
modate these different patient responses and needed 
to take account of their fatigue and frustration with not 
being able to do things that were once normal everyday 
skills.
Two of the clinicians indicated that they had greater 
confidence in running tests for people with PCA after 
the testing with the three patients. They both had expe-
rience of previous patients where it was harder to carry 
out testing. The clinicians were interested to discuss how 
what they had learnt from the research could be put into 
practice within their own work settings. Making changes 
such as splitting testing into two parts could help to alle-
viate some of the fatigue and distraction. This would not 
just apply to PCA patients, but also those with other forms 
of dementia.
The optometrist raised the issue of the length of the 
average sight test during a standard day’s practice. The 
traditional 20 min test was clearly insufficient for what 
was involved. She found a good pattern was to alternate 
30 min and 45 min tests, allowing scope for patients with 
more complex needs (56/57 merged coding).
Discussions between clinicians reflected patient 
concerns about the time that it took to get a correct diag-
nosis of PCA. Some issues reflected wider problems about 
the lack of training to work with patients with dementia. 
A benefit of the research process was that it had brought 
together optometry, ophthalmology and neurology. 
However, there was a lack of awareness throughout the 
different disciplines about PCA and this would need to be 
tackled in the future. The involvement of primary care, 
particularly GPs would also be vital to this.
People aren’t making the diagnosis always and 
they’re getting misdiagnoses or the patient’s being pi-
geon-holed in the wrong place. (76 merged coding)
Future research implications
Clinicians expressed particular interest in the implica-
tions of this project and its exploration of tests and the 
testing process. This was discussed during their one to 
one interviews, but particularly in the focus group. It was 
apparent that there were two broad areas for taking the 
research forwards. First, it was important to gain greater 
clarity about the numbers of patients with PCA within the 
broader spectrum of people with dementia. Second, there 
needed to be greater awareness of PCA by making use of 
development opportunities across the different profes-
sions, and data about the current level of understanding 
would provide a baseline against which to measure educa-
tional interventions.
Greater clarity about numbers could be achieved by 
re-analysing previous tests which have been used on 
a larger scale and included full and fragmented letters 
as part of the wider test. It may also be possible to add 
this element to new research as well. However, discus-
sion emphasised that looking at numbers alone was not 
enough. If clinicians could not recognise PCA, they would 
not be able to diagnose it from the sometimes contra-
dictory information they may come across from testing 
patients.
The low hanging fruit as far as a simple research 
question goes is: what are the three or four things 
which if you've got two or more of them then you 
are really thinking, it’s not just an eyesight thing 
it’s a brain thing? A test like that could be done in 
30 s. (62 merged coding)
It was suggested that one way to establish a baseline of 
understanding of dementia and PCA in particular would 
be, ‘to run some short surveys with medical students 
across optometry, ophthalmology and neurology to gain a 
clearer understanding of current levels of awareness' (95 
merged coding). This would help to develop such base-
line data across the relevant professions.
Previous research19 has shown that there is a strong asso-
ciation between visual impairment and the likelihood of 
being in residential care. The prevalence of visual impair-
ment from all causes was found to be more than 2.5 times 
greater in residential home settings, even allowing for age 
and severity of dementia. Improving people’s visual func-
tioning will help their quality of life and increase their 
chances of staying out of residential care.
I’m always worried that we work in a specialist centre 
and we get people with particular diagnoses and we’ve 
got very little idea of how representative our sample is 
of the rest of the world. (103 merged coding)
Further research into screening tests for PCA is vital, 
and was considered to be an important follow-up to this 
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pilot research by all the clinicians. This would involve 
identifying a small group of tests, such as the full and 
fragmented letters test, and trying them on different 
groups of patients. However, a significant factor with any 
screening test could be the number of false positives, 
which it was suggested might lead to too many referrals 
to neurology. More elaborate research follow-up could 
include running tests with a group of patients with PCA, 
a group with typical, memory-led Alzheimer’s disease and 
an appropriate control group (or groups). There may 
also be other outcomes from existing surveys and other 
research that has already been completed, which could 
be aggregated into a literature review.
Existing research has shown that there is a stark differ-
ence in the mean onset age for PCA compared with 
Alzheimer’s disease. A participant pointed out that for 
PCA this age is 59, while it is at least 20 years later for 
Alzheimer’s disease (94 merged coding).
limitations
Clinicians expressed some reservations about the fact 
that tests had only been tried on three patients. It may 
be important to look at a wider range of patients as this 
could highlight other issues that might not be apparent 
from this small sample. Given the relatively early average 
age of onset of PCA, the ages of the participants in this 
explorative study means that additional data from people 
living with earlier PCA would be important to gather in 
subsequent research.
The neurologist thought that the project’s test process 
could have benefited from the use of a wider range of 
screening tests. It is possible that some of these would 
prove more effective than others. Also, one clinician 
thought that it had not yet been possible to test the limits 
of what the patients could manage within the require-
ments of the research setting (105 merged coding) and 
the resources for testing available, which had not been as 
extensive as in their usual clinical settings.
However, there was agreement among the clinicians 
that patients had done much better on the tests than 
might be expected, given their complex range of prob-
lems (59 merged coding). This is positive as it provides 
some further support for the finding that many people 
living with dementia could complete most of the key 
elements of a standard sight test.19
COnClusIOns
A simple test which contrasted full and fragmented 
images or letters was agreed to be the test that provided 
clearest evidence of PCA, or symptoms of other cortical 
vision problems, as patients could identify the full image 
but not the fragmented one. More generally, the clini-
cians felt that simpler, shorter objective tests appeared to 
be generally more accessible to the patient participants 
than more complex, longer or more subjective ones. The 
benefit of support from partners within the examination 
environment itself was also clear.
A key priority for patients and their partners was that 
systems were in place to facilitate early identification of 
cortical perceptual problems and to have these referred 
into the appropriate secondary care service to enable a 
clear diagnosis of PCA (or other neurological condi-
tion causing the problem) to be confirmed. This meant 
that a consistent approach was needed across optom-
etry, ophthalmology and neurology, with effective and 
prompt communication and referrals between clinicians, 
to prevent excessive and unnecessary delay in diagnosis. 
These concerns were echoed by the clinical professionals 
who acknowledged the difficulty many health profes-
sionals would currently be likely to have in making clear 
discriminations between optical/ocular and cortical 
vision problems.
The test process needs to be flexible enough to accom-
modate atypical patient responses, and needs to take 
account of these patients’ fatigue in general, and also 
their frustration with not being able to do things that 
were once normal everyday skills.
The professional participants in this explorative research 
project strongly agreed that future research should clarify 
numbers with PCA, establish cross-profession knowledge 
and skills in this area, and work on further screening tests 
for PCA, and although limited in scope and execution, 
the project supports existing evidence that there are suit-
able eye examination tests that people with dementia can 
engage with and complete.
reCOMMenDAtIOns
The outcomes from this project suggested that there were 
a number of recommendations which could be taken 
forward.
1. Refine and simplify optometric and ophthalmologi-
cal tests to make them more effective for patients with 
PCA or dementia more widely, and undertake research 
to find out how these work in practice with larger and 
more varied cohorts of patients.
2. Include the full and fragmented letters test and related 
tests from the Queen Square Screening Test for Visual 
Deficits16 used by neurologists as part of the research 
outlined in point 1, and examine their effectiveness in 
differentiating between optical/ocular and cortical vi-
sion problems (caused by conditions such as PCA) in 
order to develop understanding of their potential to 
aid clinicians in primary and secondary care settings 
to discriminate between visual problems with optical/
ocular causes and those with cortical causes.
3. Develop professional learning materials to raise aware-
ness of PCA.
4. Develop concise resources for patients with dementia 
so they can make the most of their eye test.
5. Review previous research to identify what indications 
there are about the prevalence of PCA in the UK.
Acknowledgements The research team would like to thank all of the participants 
in the project: people living with PCA, family members who supported them to 
 o
n




pen: first published as 10.1136/bmjopen-2017-020905 on 20 March 2019. Downloaded from 
10 Bowen M, et al. BMJ Open 2019;9:e020905. doi:10.1136/bmjopen-2017-020905
Open access 
take part and the clinicians who took part. We would also like to acknowledge the 
contributions made by members of the UCL PCA Support Group, who provided 
advice on the initial development of the research question and on the feasibility 
of the proposed approach to the project/project design. The team would also 
like to acknowledge the support provided by Topcon UK through the generous 
loan of items of optometric equipment. The generous assistance of Mycal Miller, 
who filmed all of the participant interviews and sight testing is also gratefully 
acknowledged. 
Contributors All of the co-authors were involved from the outset in the design and 
development of the project and the research protocol. MB codrafted the manuscript 
with HZ and reviewed and approved the final draft for submission. MC redrafted 
the manuscript and approved the final draft for submission. SC reviewed drafts 
of the manuscript and approved the final draft for submission. TS reviewed drafts 
of the manuscript and approved the final draft for submission. HZ undertook the 
interviews and led the Focus Group as part of the project, codrafted the manuscript 
and reviewed and approved the final draft for submission.
Funding This work was funded by the College of Optometrists and University 
College London. TS was supported by an Alzheimer’s Research UK Research 
Fellowship. SC was supported by a grant from ESRC/NIHR (ES/L001810/1). 
Competing interests None declared.
Patient consent for publication Not required.
ethics approval The study was approved by the Queen Square Research Ethics 
Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The unedited transcripts of the interviews are held by the 
College. They are not currently publicly available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: 
clinical characteristics and differences compared to Alzheimer's 
disease. Dement Geriatr Cogn Disord 2002;14:33–40.
 2. Rizzo M, Vecera SP. Psychoanatomical substrates of Bálint's 
syndrome. J Neurol Neurosurg Psychiatry 2002;2002:162–78.
 3. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, 
and neuropathologic characteristics of posterior cortical atrophy. 
Neurology 2004;63:1168–74.
 4. Crutch SJ, Schott JM, Rabinovici GD, et al. Alzheimer's Association 
ISTAART Atypical Alzheimer's Disease and Associated Syndromes 
Professional Interest Area. Consensus classification of posterior 
cortical atrophy. Alzheimer’s & Dementia 2017:30040–7.
 5. Snowden JS, Stopford CL, Julien CL, et al. Cognitive phenotypes in 
alzheimer's disease and genetic risk. Cortex 2007;43:835–45.
 6. Galton CJ, Patterson K, Xuereb JH, et al. Atypical and typical 
presentations of Alzheimer's disease: a clinical, neuropsychological, 
neuroimaging and pathological study of 13 cases. Brain 
2000;123:484–98.
 7. Schott JM, Crutch SJ, Carrasquillo MM, et al. Genetic risk factors 
for the posterior cortical atrophy variant of Alzheimer's disease. 
Alzheimers Dement 2016;12:862–71.
 8. Yong KX, Shakespeare TJ, Cash D, et al. (Con)text-specific effects 
of visual dysfunction on reading in posterior cortical atrophy. Cortex 
2014;57:92–106.
 9. Zakzanis KK, Kielar A, Young DA, et al. Neuropsychological 
differentiation of late onset schizophrenia and frontotemporal 
dementia. Cogn Neuropsychiatry 2001;6:63–77.
 10. Crutch SJ, Lehmann M, Schott JM, et al. Posterior cortical atrophy. 
Lancet Neurol 2012;11:170–8.
 11. Kitzinger J. Qualitative research. Introducing focus groups. BMJ 
1995;311:299–302.
 12. Owsley C, McGwin G, Scilley K, et al. Perceived barriers to care 
and attitudes about vision and eye care: focus groups with older 
African Americans and eye care providers. Invest Ophthalmol Vis Sci 
2006;47:2797–802.
 13. Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma 
medications: a qualitative research study. Eye 2009;23:924–32.
 14. Laine C, Davidoff F, Lewis CE, et al. Important elements of outpatient 
care: a comparison of patients' and physicians' opinions. Ann Intern 
Med 1996;125:640–5.
 15. University College. London rare dementias group – PCA support 
group. www. raredementiasupport. org
 16. UCL. Queen Square tests for visual and cognitive deficits (Green 
Book and Blue Book) are available here. https:// onlinestore. ucl. ac. 
uk/ product- catalogue/ faculty- of- brain- sciences- c07/ ucl- institute- 
of- neurology- d07/ d07- the- queen- square- screening- test- for- visual- 
deficits
 17. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting 
qualitative research (COREQ): a 32-item checklist for interviews and 
focus groups. Int J Qual Health Care 2007;19:349–57.
 18. O'Brien BC, Harris IB, Beckman TJ, et al. Standards for reporting 
qualitative research: a synthesis of recommendations. Acad Med 
2014;89:1245.
 19. Bowen M, Edgar DF, Hancock B, et al. The Prevalence of Visual 
Impairment in People with Dementia (the PrOVIDe study): a 
cross-sectional study of people aged 60–89 years with dementia 
and qualitative exploration of individual, carer and professional 
perspectives. Health Services and Delivery Research 2016;4:1–200.
 20. Pope C, Ziebland S, Mays N. Qualitative research in health care. 
Analysing qualitative data. BMJ 2000;320:114–6.
 21. Glen FC, Baker H, Crabb DP. A qualitative investigation into patients' 
views on visual field testing for glaucoma monitoring. BMJ Open 
2014;4:e003996.
 22. Amsler Chart. American macular degeneration foundation – Amsler 
Chart. https://www. macular. org/ amsler- chart
 23. Pelak VS, Smyth SF, Boyer PJ, et al. Computerized visual field 
defects in posterior cortical atrophy. Neurology 2011;77:2119–22.
 24. Faes L, Bodmer NS, Bachmann LM, et al. Diagnostic accuracy 
of the Amsler grid and the preferential hyperacuity perimetry in 
the screening of patients with age-related macular degeneration: 
systematic review and meta-analysis. Eye 2014;28:788–96.
 25. Beh SC, Muthusamy B, Calabresi P, et al. Hiding in plain sight: a 
closer look at posterior cortical atrophy. Pract Neurol 2015;15.  o
n




pen: first published as 10.1136/bmjopen-2017-020905 on 20 March 2019. Downloaded from 
